Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation

Science

Volumn 347, Issue 6218, 2015, Pages 170-175

  Cullen, T W ^a   Schofield, W B ^a   Barry, N A ^a   Putnam, E E ^a   Rundell, E A ^a   Trent, M S ^a   Degnan, P H ^b   Booth, C J ^c   Yu, H ^d   Goodman, A L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; LIPID A; LIPID A 4'-PHOSPHATASE; PHOSPHATASE; POLYMYXIN B;

ANTIMICROBIAL ACTIVITY; COMMENSAL; MICROBIAL COMMUNITY; PATHOGEN; PEPTIDE; PHOSPHATE GROUP;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTEROIDES THETAIOTAOMICRON; CITROBACTER RODENTIUM; COMMENSAL; DELETION MUTANT; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BACTEROIDES; COLITIS; DRUG EFFECTS; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; GENETICS; GERMFREE ANIMAL; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUSE; PHYSIOLOGY; SYMBIOSIS;

BACTEROIDES THETAIOTAOMICRON; BACTEROIDETES;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTEROIDES; COLITIS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; GERM-FREE LIFE; HUMANS; LIPID A; MICE; MICROBIOTA; PHOSPHORIC MONOESTER HYDROLASES; POLYMYXIN B; SYMBIOSIS;

EID: 84923273687     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1260580     Document Type: Article

References (23)

1. J. Langhorst et al., Am. J. Gastroenterol. 104, 404-410 (2009).
2. L. V. Hooper, D. R. Littman, A. J. Macpherson, Science 336, 1268-1273 (2012).
3. J. J. Faith et al., Science 341, 1237439 (2013).
4. M. Vaara, Microbiol. Rev. 56, 395-411 (1992).
5. J. Qin et al., Nature 464, 59-65 (2010).
6. T. Icho, C. R. Raetz, J. Bacteriol. 153, 722-730 (1983).
7. T. W. Cullen et al., PLOS Pathog. 7, e1002454 (2011).
8. S. R. Coats, T. T. To, S. Jain, P. H. Braham, R. P. Darveau, Int. J. Oral Sci. 1, 126-135 (2009).
9. X. Wang, S. C. McGrath, R. J. Cotter, C. R. Raetz, J. Biol. Chem. 281, 9321-9330 (2006).
10. S. R. Coats et al., Infect. Immun. 79, 203-210 (2011).
11. R. Mundy, T. T. MacDonald, G. Dougan, G. Frankel, S. Wiles, Cell. Microbiol. 7, 1697-1706 (2005).
12. E. M. Mallick et al., Front. Microbiol. 3, 11 (2012).
13. A. L. Goodman et al., Cell Host Microbe 6, 279-289 (2009).
14. J. L. Round, S. K. Mazmanian, Nat. Rev. Immunol. 9, 313-323 (2009).\
15. H. Chung et al., Cell 149, 1578-1593 (2012).
16. S. M. Lee et al., Nature 501, 426-429 (2013).
17. S. Vaishnava et al., Science 334, 255-258 (2011).
18. E. T. Rietschel et al., FASEB J. 8, 217-225 (1994).
19. T. W. Cullen, M. S. Trent, Proc. Natl. Acad. Sci. U.S.A. 107, 5160-5165 (2010).
20. N. L. Que-Gewirth et al., J. Biol. Chem. 279, 25420-25429 (2004).
21. D. Kanistanon et al., PLOS Pathog. 4, e24 (2008).
22. N. J. Phillips, B. Schilling, M. K. McLendon, M. A. Apicella, B. W. Gibson, Infect. Immun. 72, 5340-5348 (2004).
23. R. S. Munford, Infect. Immun. 76, 454-465 (2008).